Aberrant leukocyte telomere length in Birdshot Uveitis by Vazirpanah, N. (Nadia) et al.
RESEARCH ARTICLE
Aberrant leukocyte telomere length in
Birdshot Uveitis
Nadia Vazirpanah1*, Fleurieke H. Verhagen1, Anna Rothova2, Tom O. A. R. Missotten3,
Mirjam van Velthoven3, Anneke I. Den Hollander4, Carel B. Hoyng4, Timothy.R. D.
J. Radstake1,5☯, Jasper C. A. Broen1,5☯, Jonas J. W. Kuiper1,6☯
1 Laboratory of Translational Immunology, department of Immunology, University Medical Center Utrecht,
Utrecht, The Netherlands, 2 Department of Ophthalmology, Erasmus University Medical Center, Rotterdam,
The Netherlands, 3 The Rotterdam Eye Hospital, Rotterdam, The Netherlands, 4 Department of
Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands, 5 Department of Clinical
Immunology and Rheumatology, University Medical Center Utrecht, Utrecht, The Netherlands, 6 Ophthalmo-
Immunology, Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands
☯ These authors contributed equally to this work.
* N.Vazirpanah@umcutrecht.nl
Abstract
Purpose
Birdshot Uveitis (BU) is an archetypical chronic inflammatory eye disease, with poor visual
prognosis, that provides an excellent model for studying chronic inflammation. BU typically
affects patients in the fifth decade of life. This suggests that it may represent an age-related
chronic inflammatory disease, which has been linked to increased erosion of telomere
length of leukocytes.
Methods
To study this in detail, we exploited a sensitive standardized quantitative real-time polymer-
ase chain reaction to determine the peripheral blood leukocyte telomere length (LTL) in 91
genotyped Dutch BU patients and 150 unaffected Dutch controls.
Results
Although LTL erosion rates were very similar between BU patients and healthy controls, we
observed that BU patients displayed longer LTL, with a median of log (LTL) = 4.87 (= 74131
base pair) compared to 4.31 (= 20417 base pair) in unaffected controls (P<0.0001). The
cause underpinning the difference in LTL could not be explained by clinical parameters,
immune cell-subtype distribution, nor genetic predisposition based upon the computed
weighted genetic risk score of genotyped validated variants in TERC, TERT, NAF1, OBFC1
and RTEL1.
Conclusions
These findings suggest that BU is accompanied by significantly longer LTL.
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Introduction
Birdshot Uveitis (BU) is an archetypical and clinically well-defined inflammatory eye disease
(uveitis) that damages retina and choroid tissues commonly leading to visual deterioration[1].
Although the cause of BU is not understood, it is characterized by ocular infiltrating and circu-
lating inflammatory T lymphocytes[2–5] and exclusively affects major histocompatibility com-
plex human leukocyte antigen (HLA)-A29-positive individuals[6,7]. BU typically manifests in
the fifth decade of life[8,9]. This might imply that BU is an disease characterized by age-related
failure of immune regulation and progressive chronic subclinical inflammation, eventually
leading to uveitis in genetically susceptible individuals[10,11].
Telomeres are tandem repeat regions at the ends of eukaryotic chromosomes that shorten
with increasing age as part of the normal ageing process[12]. The relative length of cellular
telomeres is therefore considered to be an index for cellular senescence. Excessive erosion of
telomeres in leukocytes was suggested to indicate persistent replicative stress. In line with this,
leukocytes from patients with chronic inflammatory diseases often display an increased rate of
telomere erosion, likely to be caused by persistent inflammation or genetic susceptibility affect-
ing telomere biology genes[12,13].
In this study, we investigated the leukocyte telomere length in a unique cohort of genotyped
BU patients and unaffected healthy controls.
Patients and methods
This study was performed in compliance with the guidelines of the Declaration of Helsinki
and has the approval of Institutional Review Boards and ethical committee of the University
Medical Center Utrecht. After signed inform consent, blood was obtained from 91 unrelated
Dutch BU cases at the Department of Ophthalmology at the University Medical Center
Utrecht, the Eye Hospital Rotterdam and Radboud University Nijmegen Medical Center, the
Netherlands. 150 unrelated Dutch healthy controls all from European ancestry were used as
controls (Table 1). The diagnosis of BU was based on international guidelines[14]. Disease
duration was typically between 5–10 years.
Table 1. Demographics of discovery and replication cohorts investigated in this study.
Birdshot Uveitis Unaffected Control P value
N 91 150
Female/Male (ratio) 69/22 (3.0) 122/28 (4.4) 0.259c
Age (years) 60.5 (9.07) 52.9 (7.16) <0.0001
Leukocyte Telomere Length (base pares) 74460.48 (126832.15) 20310.00 (44573.73) <0.0001
% of patients % of unaffected controls
No systemic treatment 27a 100
Systemic Corticosteroids 25a 0
IMT 31a 0
Systemic Corticosteroids + IMT 17a 0
Active uveitis 20b 0
a IMT = immunomodulatory treatment
b n = 71
c n = 50.
The values are represented in Median (Standard deviation). The significance of the association between patients and unaffected control was tested using
Chi-square test (categorical values) and Mann-Whitney U test (continuous variables).
https://doi.org/10.1371/journal.pone.0176175.t001
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Measurements of absolute telomere length in leukocytes
Whole blood EDTA samples were obtained from all participants. DNA extraction was similar
for cases and controls and conducted by automated magnetic bead-based DNA isolation pro-
tocols (PerkinElmer). DNA concentration was quantified by Qbit Fluorometric Quantitation
(Thermofischer Scientific). Leukocyte Telomere Length (LTL) was measured by Bio-rad cfx-
96 real-time qualitative polymerase chain reaction (qPCR) detection system in duplicates in
two separate experiments.
Briefly, the length of telomeres—long repetitive hexamer (TTAGGG) sequences–can be
accurately determined by using a calibration curve based on linear serial dilution of a synthetic
84-mer (14 consecutive TTAGGG sequences) oligonucleotide (Geneworks, Adelaide, Austra-
lia) with a predetermined molecular weight per reaction (60x10-12 gr of telomere oligomer or
1.36x109oligomers). The total number of base-pares in the highest standard can be calculated
as ((1.36x109 molecules of oligomer) x (84 oligomer length) = 1.18x108 kilo base-pares).
The relative telomere length per sample is extrapolated from serial dilutions of the synthetic
standard in each qPCR measurement. Similarly, a synthetic standard was also designed for the
single copy house-keeping gene 36B4.
Absolute telomere base-pares per genome are quantified by subdividing the total number
of telomere base-pares from 36B4 (which has only one copy per gene) following; Telomere
length/house-keeping gene = telomere length per genome [15,16]. LTL for each individual in
the study are outlined in S1 Table.
Isolation of mononuclear immune cell subsets
Peripheral blood mononuclear cells (PBMCs) of 9 BU patients and 15 matched healthy indi-
viduals (S2 Table) were sorted to obtain immune cell-subtypes separately. PBMCs were iso-
lated through Ficoll (Ficoll-Paque Plus, GE Healthcare). In order to sort out the CD3+/CD56-/
CD4+ for T helper lymphocytes, CD3+/CD56-/CD8+ for Cytotoxic T lymphocytes, CD19+/
CD20+ for B lymphocytes, CD14+ monocytes, CD3-/CD56+ NK cells and CD123 (IL3RA)+ /
CD304 (BDCA4)+ pDCs, Fluorescence Activated Cell Sorting (FACS) (FACSAria III, BD Bio-
sciences) was implemented.
Human TERT gene expression measurements
Human telomerase (hTERT) gene expression levels of the sorted cell subsets were quantified
by qPCR (Taqman Beadchip, applied Biosystems) according to the specific protocol indicated
by the manufacturer by Quantstudio (Biosystems). Gene expression was normalized to Glucu-
ronidase Beta (GUSB) and Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH).
Statistical analysis
IBM SPSS Statistics v20 (SPSS, Chicago, IL) and Graphpad Prism v6 (GraphPad Software, San
Diego, California) were used for statistical analyses as indicated in the results section. The telo-
mere length data were natural log transformed to achieve a normal distribution. The Spear-
man’s Rank-Order correlation was implied to test the association between leukocyte count of
untreated patients and LTL. The blood leukocyte count (10^9/L) was assessed in the clinic
simultaneous to patients visit. We computed a weighted genetic risk score (wGRS) in the 91
BU cases using genotype data from these cases obtained in a previous genome-wide associa-
tion study[17] to test the cumulative effect of validated SNPs associated with telomere length
[18] compared to an equivalent number of Dutch controls[17]. We calculated a weighted
mean of genotype dosage across seven established risk alleles (Table 2) by multiplying the
Immune-senescence in Birdshot Uveitis
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number of risk alleles at each locus (0, 1, 2) for the corresponding OR per allele and then sum-
ming the products[17]. We used a T-test to assess the differences between the mean absolute
values of wGRS.
Results
Table 1 provides demographic characteristics of the BU and control cohorts. After quality con-
trol, we analysed LTL data in 91 cases and 150 controls (S1 Table). Gender was equally distrib-
uted between BU and controls (Chi-Square Test, P = 0.259). The mean ages (range) of patients
with BU and controls were 60.6 (30–84) and 52.9 (31–59) years, respectively. Although the age
groups of the cases and controls were generally matched, the mean age of the BU cohort was
significantly higher (P<0.0001).
The telomere length data were natural log transformed to achieve a normal distribution. As
expected, a weak inverted linear correlation with age and LTL was demonstrated with LTL =
-0.009767age + 5.498; R2 = 0.045 (P = 0.04) for BU patients and LTL = -0.009610age + 4.95;
R2 = 0.038 (P = 0.02) for unaffected controls (Fig 1). Telomere length decreased with similar
Table 2. Seven validated SNPs17 used to compute the genetic risk score (GRS) in BU and controls.
Allele Frequency
Gene Chromosome SNP Risk allele BU Controls Odds ratio P value*
TERC 3 rs10936599 T 0.28 0.23 1.30 0.12
TERT 5 rs2736100 A 0.55 0.52 1.16 0.36
NAF1 4 rs7675998 A 0.22 0.21 1.12 0.58
OBFC1 10 rs9420907 A 0.82 0.84 0.81 0.30
ZNF208 19 rs8105767 A 0.74 0.73 1.10 0.57
RTEL1 20 rs755017 A 0.86 0.89 0.78 0.28
ACYP2 2 rs11125529 C 0.89 0.88 1.25 0.35
The significance of the association between patients and unaffected control was tested using Chi-square test. (P<0.05).
https://doi.org/10.1371/journal.pone.0176175.t002
Fig 1. Dot plot showing natural log transformed leukocyte telomere length of Dutch BU patients
(diamonds) and Dutch controls (empty circles).
https://doi.org/10.1371/journal.pone.0176175.g001
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rates in BU patients and healthy participants (difference in slopes ~ P = 0.97) with an annual
loss of [assuming (10β1–1)×100%] ~2.22% of telomere length in BU patients and 2.19% in con-
trols. BU patients displayed longer LTL (in base pair [bp]) with a median of log (LTL) = 4.87
(= 74460 bp) compared to 4.31 (= 20310 bp) in the control group (P<0.0001, Fig 2). Age-
adjusted telomere length computed by residuals derived from the linear model also supported
significantly longer LTL (>3 times [bp]) in BU (median log (LTL) = 4.630 = 42658 bp) com-
pared to controls (median log (LTL) = 4.216 = 13366 bp) (P<0.0001, Fig 3). In line with previ-
ous observations[19–21], age explained very little of the total variability of LTL (adjusted
R2<0.04 in cases and controls, Fig 1). To avoid over-fitting due to large residuals, we conserva-
tively did not correct for age in subsequent analyses.
The LTL was similar between men and women in both BU (median log (LTL) = 4.985 vs.
4.830, P = 0.328) and controls (4.310 vs. 4.310, P = 0.664, Fig 3A). We also did not observe a
Fig 2. Median of log transformed leukocyte telomere length (kilo base-pairs) values represented on scatter dot plot
showing (A) BU patients and healthy controls (P <0.0001, T-test) and (B) after adjustment for age (P <0.0001).
https://doi.org/10.1371/journal.pone.0176175.g002
Fig 3. Median of natural log transformed leukocyte telomere length (kilo base-pairs) of BU patients and controls according to (A) gender (male (M)
and female (F), P = 0.328) (B) presence of leucocytosis (C) and sytemic treatment (no treatment, (cortico)steroids, immune-modulatory treatment
(IMT) and IMT + steroids).
https://doi.org/10.1371/journal.pone.0176175.g003
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difference in LTL between patients with (n = 34) and without leucocytosis (n = 57) at the time
of sampling (Fig 3B). To investigate if treatment affected LTL, we subdivided the patients
according to available treatment data of 71 cases (Fig 3C). All of the treatment groups, includ-
ing patients who did not have a history of systemic treatment displayed significantly longer
LTL (Fig 3B). The mean LTL of patients treated with immune-modulatory treatment (IMT)
was slightly higher compared to other treatment regimes, but did not reach statistical signifi-
cance (P>0.06, Fig 3C).
We had the opportunity to study telomere length and expression of telomere biology genes
in sorted immune cell subsets of 9 BU and 15 healthy individuals. LTL differences between
CD4+ and CD8+ T lymphocytes, CD19+ B lymphocytes, CD14+ monocytes, CD3-/CD56+ nat-
ural killer (NK) cells and CD123+/CD304+ plasmacytoid dendritic cells (pDC) of BU patients
and healthy individuals did not reveal statistically significant differences in telomere length (S2
Table). Also, in contrast to house-keeping genes (GUSB and GAPDH), hTERT gene expression
was not detected in these cell subtypes (S1 Fig). Six of these BU patients were naïve to systemic
treatment and revealed slightly higher leukocyte count and a positive correlation (r = 0.551,
P>0.05) between leukocyte count and LTL. However, this observation is underpowered due to
low number of untreated patients in which leukocyte count is quantified.
Seven validated genetic variants that are known to be involved in telomere biology (TERC,
TERT, NAF1, OBFC1 and RTEL1) have been shown to significantly affect telomere-length in
age-related diseases[18]. Because BU displayed longer LTL, we investigated potential genetic
predisposition of these known risk loci in BU that could explain the difference in LTL. There-
fore, we computed a weighted genetic risk score (wGRS) based on the observed number of risk
alleles per case or control and adjusted their effect sizes based on the previous GWAS of BU
Fig 4. Distribution of the relative frequency of the weighted genetic risk score (wGRS) of validated
variants in telomere biology genes (Table 2.) of BU patients (red line) (mean wGRS [range] = 8.598
[3.650–13.34]) and healthy control participants (blue line) (mean wGRS [range] = 8.552[3.740–12.29]).
Difference between BU and healthy control participants was tested via t- test (P = 0.859).
https://doi.org/10.1371/journal.pone.0176175.g004
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[17]. The allele frequencies in cases and controls were very similar to the previous meta-analy-
ses by Codd et al, indicating that the allele distribution reflects larger populations and can be
used for good estimate of the GRS[18] (Table 2). The mean wGRS was highly similar between
BU and controls (mean wGRS[range] = 8.598[3.650–13.34] for BU and 8.552[3.740–12.29]
for controls, t-test: P = 0.859, (Fig 4). Also, the risk alleles did not show consistency in effect
direction of BU patients (in other words, positive and negative odds ratios, Table 2). These
analyses suggest that there is no genetic predisposition for telomere length in BU patients.
Based upon these findings we conclude that the increased LTL can be attributed to disease spe-
cific mechanisms.
Discussion
BU is a severe chronic inflammation of the posterior eye segment that damages ocular tissues
resulting in visual impairment. BU typically affects middle-aged and elderly individuals of
European descent[1]. Hallmark of disease is the appearance of the distinctive ‘birdshot’ pattern
of multiple white spots on the fundus, from which it obtained its name[22].
In the current study we show that leukocytes from BU patients have longer telomere length
than population-based controls. Despite extensive efforts, the mechanism behind this ob-
servation is currently enigmatic. The telomere measurement method we used has been well
described in the literature and is known for its high reproducibility[15]. In contrast to the
common use of reference samples derived from a patient, control, or cell line, we optimized
reproducibility by exploiting synthetic telomere repeats and 36B4 gene copies as standards. A
great advantage of using stable synthetic standards is the possibility for absolute quantification
of telomere lengths[16]. Since cases and control samples have been measured twice in random
order by the same qPCR machine, settings and reagents, we are confident that the difference
in LTL is unrelated to methodology.
Telomere length measurements in several immune cell-subtypes did not reveal overall
changes in telomere length of leukocytes and may be the result of a yet un sampled immune
cell-subset or would need larger sample size to investigate this at the cell subset level[23,24].
BU is a rare disease and biosamples are scarce making it hard to obtain a large patient cohort
[25], thus, we were only able to include a limited number of patients for cell sorting. Recent
studies demonstrated changes telomere length are better monitored in longitudinal studies fol-
lowing participants over a longer time course[26]. Accordingly, telomere length quantification
in following studies overtime might unravel clues on telomere biology of BU patients.
Previous studies have mapped putative loci known to be involved in telomere biology and
demonstrated association of 7 lead variants in 5 telomere regulatory genes (Table 2) with LTL
in age-related diseases[18]. This causal role of genetic predisposition in LTL led us to investi-
gate if the much longer telomeres were caused by genetic predisposition in the BU patients.
When we applied our previously published whole genome data to the trait of having longer
telomeres in the BU population, we did not observe cumulative effect of variants linked to telo-
mere length in these patients. Thus, it is reasonable to assume that there is no genetic predispo-
sition for telomere length in BU patients. Although it is possible that the sample size and
power were too low to detect such an association, the highly similar genetic risk score in cases
and controls and the lack of consistent direction of effect advocate for very low (if any) contri-
bution of genetic variants to the large difference of LTL between BU and healthy controls. This
observation, in addition to the fact that both patients and controls share the same ethnic back-
ground (cases and controls are all Dutch Caucasians from European ancestry) makes the lon-
ger telomeres unlikely the result of population stratification. Based upon these findings we
conclude that the increased LTL can be attributed to BU-specific mechanisms.
Immune-senescence in Birdshot Uveitis
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When we analysed our data from a population/demographic perspective, it appears that the
population of BU patients investigated in this study is slightly older compared to the healthy
individuals. However, when we applied age-correction based on the incremental slopes of telo-
mere shortening with age, the changes in LTL remained significant. Since we consider meth-
odological, genetic and demographic factors to be minimally involved, we assume disease
mechanisms are driving the aberrant LTL.
Whether the longer LTL is a consequence of BU or contributes to disease onset remains to
be elucidated. The present study was cross-sectional and involved measurement of telomere
length at only one time point, and no data on telomere erosion rates are available. Further-
more, telomere length can be affected by various metabolic and biological factors [27]. The
general view of chronic inflammation is that it is accompanied by shortening of leukocyte telo-
mere length due to replicative stress[28,29]. Yet, increased LTL has been reported in several
chronic inflammatory diseases[30] such as rheumatoid arthritis (RA) and ankylosing spondyli-
tis. Curiously, like BU, the latter also strongly linked to HLA class I (HLA-B27)[31,32]. In fact,
comparable studies in systemic lupus erythmatodes and RA demonstrated that longer telomere
length was particularly observed in older patients–similar to the representative age of onset in
BU[33,34].
In addition to its clinically well-described manifestations, BU is renowned outside the field
of ophthalmology for its unusually strong link with the HLA-A29. Essentially all patients are
HLA-A29 positive, which represents the strongest associations between an HLA class I allele
and human disease[35,36]. Nevertheless, the role of HLA-A29 has not yet been elucidated and
consequently the pathophysiology of BU is not well understood[1]. However, in recent years
an emerging line of evidence is beginning to yield clues on the disease biology of BU. The
recent genome-wide analysis of BU confirmed the extreme association with HLA-A29:02 and
revealed a strong link with the endoplasmic reticulum aminopeptidase 2 (ERAP2) gene, indicat-
ing that peptide processing in the endoplasmic reticulum and presentation to T cells are the
key mechanism of the disease[3]. Indeed, T cells are the dominant infiltrating cells found in
the eyes of patients[2]. The ocular microenvironment and blood of patients display elevated
levels of IL-17-related cytokines and an increased frequency of circulating T helper 17 and T
cytotoxic 17 cells. These T cell subsets are considered as important pathogenic drivers of vari-
ous chronic inflammatory disorders[5,37–39].
Another explanation might be that activated naïve T cells are able to up-regulate telomerase
expression, although this ability remains controversial[26,40–42]. In highly proliferative cells
such as stem cells, germ cells and many neoplastic cells, telomerase is decisive for telomere
maintenance. In T cells, despite being normal somatic cells, telomerase expression during pro-
liferation and an elevated telomerase activity was demonstrated in immature naïve cells as
compared to mature thymocytes, and was almost undetectable in mature resting naïve T cells
[43,44]. Although we did not observe increased telomerase expression in T cells in BU, we did
not make any distinction between the naïve and the memory T cell compartment within the
examined immune-cell panel. Interestingly, CD8+ antigen-specific T cells display more robust
inflammatory responses in individuals with longer telomere length[45] and CD4+ antigen-
specific T cells have relatively longer telomere length compared to naïve cells[46]. Since BU
patients show retinal autoimmunity, reflected by enhanced T cell proliferation towards retinal
antigens[36,47,48], the increased LTL could reflect enrichment for ocular-specific T cells that
drive chronic inflammation in BU. If longer telomere length in T cells confers risk in
HLA-A29 positive individuals for developing BU, further investigation is needed that includes
HLA-A29 positive controls. Alternatively, LTL may also be the result of other immune cell
subsets. Interestingly, plasma cell differentiation from B cells–the antibody-producing and T
cell-activating B cell population–was reported to be accompanied by a significant elongation
Immune-senescence in Birdshot Uveitis
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of telomeres of these cells[49]. Inline with this, our results indicate longer telomeres in B cells
of BU patients (S2 Table), despite the limited sample size and consequential lack of power, this
is an important observation since anti-retinal antibodies are emerging as important contribu-
tors in the pathophysiology of uveitis.
The complex dynamics of telomere biology in chronic inflammatory and autoimmune dis-
eases advocates for detailed dissection of multiple epigenetic mechanisms in distinct cell subsets.
In conclusion, BU patients show longer telomeres compared to healthy controls which
implies sophisticated telomere biology in chronic inflammation that warrants further research
into the leukocyte populations involved in BU.
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